Publication:Report
Developing countries are the main providers of genetic resources and traditional knowledge. Conversely, most intellectual property rights (IPRs) on seeds and medicines are concentrated in developed countries. This has some disadvantages for developing countries. Thus, patents on seed or pharmaceutical products sometimes make the access to such products for the poor more difficult and expensive; there are hardly any positive effects of IPRs on fighting poverty by contrast. This is the result of a study for the European Parliament that Ecologic Institute helped to write. The study, which was written by Ecologic Institute (Christiane Gerstetter, Christine Lucha, Katriona McGlade and Elizabeth Tedsen) and Vrije Universiteit Brussel is available for download.